Impact of Tight Glycaemic Control in Acute Myocardial Infarction

• Status: Terminated
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine whether tight glycaemic control with insulin improves myocardial function and myocardial perfusion (measured by myocardial contrast echocardiography) and novel vascular risk factors in patients with acute myocardial infarction and hyperglycaemia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Melbourne Health
• Collaborators: Bristol-Myers Squibb; National Health and Medical Research Council, Australia
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Age >=18years

• Acute Myocardial Infarction

• Blood Glucose Level >=10mmol/L

• Wall motion abnormality on baseline echocardiogram

Exclusion Criteria:

• Active infection/inflammation

• Cardiac shunt

• Cognitive Impairment

• Insulin allergy